Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2005
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054685 Pharmaceutical composition
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054650 Suppression tumor growth
03/10/2005US20050054645 Aids therapy; side effect reduction
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054619 Suppression tumor growth
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054585 Using saccharide; bone disorders
03/10/2005US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054579 New crystalline forms
03/10/2005US20050054577 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent
03/10/2005US20050054567 Polypeptides; adjust concentration of stem cells
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054037 Ferroportin-1 mutant
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053661 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/10/2005US20050053654 able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt and a binder, in the form of a coated granule, and excipients such as disintegrating agent, a soluble diluent, and a lubricant
03/10/2005US20050053641 Method of treating irritable bowel syndrome
03/10/2005US20050053603 Monocyte chemoattractant protein for treatment of liver diseases and antibodies thereof
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053583 Method of inhibiting prion protein
03/10/2005US20050053575 Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same
03/10/2005US20050053572 Does not cause any side effects and has superior hair growth-promoting effects
03/10/2005US20050053556 Administering subcitrate, aluminate, oxide, salicylate, subgallate, stannate, phosphate, tribromphenate, subcarbonatate, subnitrate, and/or sodium tartrate salt of bismuth to treat halitosis associated with sulfite-reducing bacteria in gut
03/10/2005DE202004019875U1 Composition useful for modifying the vaginal pH of pregnant women to influence the sex of the baby has an acidic or basic pH and a defined viscosity
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/09/2005EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease
03/09/2005EP1512683A1 Novel opiate compounds, methods of making and methods of use
03/09/2005EP1512408A1 Antibacterial agent and antibacterial composition
03/09/2005EP1512403A1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
03/09/2005EP1512402A1 Inhibitors against complex ii of electron transport system
03/09/2005EP1512399A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
03/09/2005EP1512398A1 Intravascular stent with cytoskeletal inhibitors for the prevention of restenosis
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511765A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511757A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
03/09/2005EP1511752A2 Camptothecins with a modified lactone ring
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511735A1 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS
03/09/2005EP1511723A1 Sulfone liver x-receptor modulators
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1511519A1 Modified byrodin 1 with reduced immunogenicity
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511511A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511489A1 New pharmaceutical compositions containing flibanserin polymorph a
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511487A1 Novel formulation for the parenteral application of crobenetine
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1511394A1 Probiotics and oral tolerance
03/09/2005EP1511393A1 A method of improving the growth performance of an animal
03/09/2005EP1451188B1 4-(oxadiazol-3-yl)-1,4-diazabicyclo 3.2.2]-nonane derivatives, preparation and therapeutic use thereof
03/09/2005EP1448053A4 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
03/09/2005EP1432407B1 Lisinopril compositions having large-particle dcpd
03/09/2005EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds
03/09/2005EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 1564